Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma

Patients with multiple myeloma are at elevated risk of venous thromboembolism (VTE), the second leading cause of death in patients with cancer, but physician adherence to VTE prevention guidelines is low. Several organizations partnered in designing and implementing a 2-year quality improvement (QI)...

Full description

Bibliographic Details
Main Authors: Rachid Baz MD, Roy Furman MD, PhD, Katherine Simondsen PharmD, BCOP, Christine Stone PhD, MBA
Format: Article
Language:English
Published: SAGE Publishing 2020-06-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820930204
id doaj-a3b5cddfc57340ea8145a5533abdc85c
record_format Article
spelling doaj-a3b5cddfc57340ea8145a5533abdc85c2020-11-25T03:20:16ZengSAGE PublishingCancer Control1073-27482020-06-012710.1177/1073274820930204Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple MyelomaRachid Baz MD0Roy Furman MD, PhD1Katherine Simondsen PharmD, BCOP2Christine Stone PhD, MBA3 Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA American Diabetes Association, Bala Cynwyd, PA, USA Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA Haymarket Medical Education, Paramus, NJ, USAPatients with multiple myeloma are at elevated risk of venous thromboembolism (VTE), the second leading cause of death in patients with cancer, but physician adherence to VTE prevention guidelines is low. Several organizations partnered in designing and implementing a 2-year quality improvement (QI) program in a tertiary care/academic cancer center, to increase awareness of VTE prophylaxis for patients with multiple myeloma and thus improve adherence to prophylaxis guidelines and protocols. The QI arm included 2 chart audits, conducted 2 years apart, of unmatched cohorts of 100 patients with multiple myeloma. An Education arm included 2 grand rounds presentations, 3 web-based case discussions, and a patient education module. Twenty providers took part in the continuous QI arm. More than 1100 learners participated in the online cases; the patient education curriculum reached 112 multiple myeloma patients. The initiative proved helpful in defining barriers to guideline adherence and identifying data-driven practice improvement strategies for VTE prophylaxis. It also increased learner awareness of VTE guidelines, patient risk stratification, and optimal thromboprophylaxis strategies. There was a reduction in VTE events (primary clinical outcome) from 10% at baseline to 4% in the follow-up cohort, although this was not statistically significant. Higher rates of guideline-based prophylaxis were observed in low-risk patients, and a lower incidence of VTE was observed in multiple myeloma patients with a prior history of VTE. Additional research is needed to refine prophylaxis guidelines. With appropriate institutional support, this type of QI program can be readily adopted by other organizations to address practice improvement needs.https://doi.org/10.1177/1073274820930204
collection DOAJ
language English
format Article
sources DOAJ
author Rachid Baz MD
Roy Furman MD, PhD
Katherine Simondsen PharmD, BCOP
Christine Stone PhD, MBA
spellingShingle Rachid Baz MD
Roy Furman MD, PhD
Katherine Simondsen PharmD, BCOP
Christine Stone PhD, MBA
Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
Cancer Control
author_facet Rachid Baz MD
Roy Furman MD, PhD
Katherine Simondsen PharmD, BCOP
Christine Stone PhD, MBA
author_sort Rachid Baz MD
title Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
title_short Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
title_full Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
title_fullStr Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
title_full_unstemmed Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
title_sort quality improvement at an academic cancer center: venous thromboembolism prophylaxis in patients with multiple myeloma
publisher SAGE Publishing
series Cancer Control
issn 1073-2748
publishDate 2020-06-01
description Patients with multiple myeloma are at elevated risk of venous thromboembolism (VTE), the second leading cause of death in patients with cancer, but physician adherence to VTE prevention guidelines is low. Several organizations partnered in designing and implementing a 2-year quality improvement (QI) program in a tertiary care/academic cancer center, to increase awareness of VTE prophylaxis for patients with multiple myeloma and thus improve adherence to prophylaxis guidelines and protocols. The QI arm included 2 chart audits, conducted 2 years apart, of unmatched cohorts of 100 patients with multiple myeloma. An Education arm included 2 grand rounds presentations, 3 web-based case discussions, and a patient education module. Twenty providers took part in the continuous QI arm. More than 1100 learners participated in the online cases; the patient education curriculum reached 112 multiple myeloma patients. The initiative proved helpful in defining barriers to guideline adherence and identifying data-driven practice improvement strategies for VTE prophylaxis. It also increased learner awareness of VTE guidelines, patient risk stratification, and optimal thromboprophylaxis strategies. There was a reduction in VTE events (primary clinical outcome) from 10% at baseline to 4% in the follow-up cohort, although this was not statistically significant. Higher rates of guideline-based prophylaxis were observed in low-risk patients, and a lower incidence of VTE was observed in multiple myeloma patients with a prior history of VTE. Additional research is needed to refine prophylaxis guidelines. With appropriate institutional support, this type of QI program can be readily adopted by other organizations to address practice improvement needs.
url https://doi.org/10.1177/1073274820930204
work_keys_str_mv AT rachidbazmd qualityimprovementatanacademiccancercentervenousthromboembolismprophylaxisinpatientswithmultiplemyeloma
AT royfurmanmdphd qualityimprovementatanacademiccancercentervenousthromboembolismprophylaxisinpatientswithmultiplemyeloma
AT katherinesimondsenpharmdbcop qualityimprovementatanacademiccancercentervenousthromboembolismprophylaxisinpatientswithmultiplemyeloma
AT christinestonephdmba qualityimprovementatanacademiccancercentervenousthromboembolismprophylaxisinpatientswithmultiplemyeloma
_version_ 1724618481412866048